Patient with recurrent glioblastoma started novottf therapy on (b)(6) 2013.Novocure was informed that the patient died.Date of death was (b)(6) 2013.Per nurse at the prescribing site, cause of death was gbm progression, not related to novottf therapy.Patient had a rapidly progressing disease and died in hospice so no hospital summary was available.No adverse events associated with device use were reported.The last date of novottf therapy was not known until the equipment was returned to novocure and logfiles downloaded on (b)(6) 2013.Per logfile review, last device use was (b)(6) 2013, at 15:34 and device was functioning as per normal operating conditions.
|